Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3739366012 | Cromolyn and xylometazoline only product in nasal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3739367015 | Product containing only cromoglicic acid and xylometazoline in nasal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3739368013 | Cromoglicic acid and xylometazoline only product in nasal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3739366012 | Cromolyn and xylometazoline only product in nasal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3739367015 | Product containing only cromoglicic acid and xylometazoline in nasal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3739368013 | Cromoglicic acid and xylometazoline only product in nasal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Is a | True | Cromoglicic acid and xylometazoline only product in nasal dose form | Inferred relationship | Existential restriction modifier (core metadata concept) |
This concept is not in any reference sets